Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Healthtrust
Queensland Health
Chubb
Covington
Argus Health
Fuji
Deloitte

Generated: June 20, 2018

DrugPatentWatch Database Preview

Diphenhydramine citrate; ibuprofen - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for diphenhydramine citrate; ibuprofen and what is the scope of diphenhydramine citrate; ibuprofen patent protection?

Diphenhydramine citrate; ibuprofen
is the generic ingredient in two branded drugs marketed by Pfizer, Dr Reddys Labs Ltd, and Perrigo R And D, and is included in three NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Diphenhydramine citrate; ibuprofen has twelve patent family members in ten countries.

There are twenty-three drug master file entries for diphenhydramine citrate; ibuprofen. Thirty-three suppliers are listed for this compound.
Summary for diphenhydramine citrate; ibuprofen
International Patents:12
US Patents:1
Tradenames:2
Applicants:3
NDAs:3
Drug Master File Entries: 23
Suppliers / Packagers: 33
Clinical Trials: 1,219
DailyMed Link:diphenhydramine citrate; ibuprofen at DailyMed

US Patents and Regulatory Information for diphenhydramine citrate; ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D IBUPROFEN AND DIPHENHYDRAMINE CITRATE diphenhydramine citrate; ibuprofen TABLET;ORAL 079113-001 Dec 22, 2008 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd IBUPROFEN AND DIPHENHYDRAMINE CITRATE diphenhydramine citrate; ibuprofen TABLET;ORAL 090619-001 Jul 8, 2009 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer ADVIL PM diphenhydramine citrate; ibuprofen TABLET;ORAL 021394-001 Dec 21, 2005 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for diphenhydramine citrate; ibuprofen

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,883,849 Treatment of sleep disturbances ➤ Try a Free Trial
9,155,718 Treatment of sleep disturbances ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Colorcon
Cipla
Medtronic
Citi
Mallinckrodt
UBS
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.